Company Revenue

Excluding its divested spinal implant business, Stryker's orthopedic sales grew double-digits in the second quarter of 2025....

The company's orthopedic business remains challenged by supply chain troubles, but BioBrace and foot and ankle have been bright spots....

The company's orthopedic growth declined for the second consecutive quarter but new products are set to bolster second half performance....

Current position, sales performance and recent developments for Treace Medical, Xtant Medical and BONESUPPORT....

The company grew in the mid-single-digits during its fiscal 2025 on the strength of its differentiated enabling technology....

The company grew in the low double digits in 1Q25 on the strength of new product introductions and robust international...

The company grew in the mid-teens and could see even greater demand with MACI Arthro's use for trochlea defects....

The company's orthopedic sales declined about 10% in the first quarter of 2025, but its commercial channel showed ample promise....

The company grew in the low single digits for the first quarter of 2025 and expects accelerating growth through the...

The company faced market softness, supply issues and international order timing lumpiness as it declined in the low single digits....